有氧运动通过抑制miR-3473e来激活EphB2-依赖的NMDA/AMPA受体信号传递来拯救早期阿尔茨海默病中的突触可塑性
Xiangli Tong1, Zhen Tong1, Weijia Wu1
1Hunan Provincial Key Laboratory of Physical Fitness and Sports Rehabilitation, Hunan Normal University, Changsha, 410012, China.
Neurochemistry international
|July 27, 2025
概括
有氧运动通过减少miR-3473e.改善早期阿尔茨海默病 (AD) 的记忆和学习. 这种运动干预增强了突触可塑性并清除了粉样质斑块,为AD提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 运动生理学 运动生理学
背景情况:
- 早期阿尔茨海默病 (AD) 的特点是认知能力下降,与突触可塑性受损有关.
- 运动干预措施对认知增强有希望,但潜在的分子机制尚未完全理解.
- 微RNAs (miRNAs) 是运动诱导的突触改善的潜在内源调节者.
研究的目的:
- 调查有氧运动改善早期AD认知功能的分子机制.
- 为了确定参与调解运动的突触益处的特定miRNAs.
- 阐明miR-3473e在运动诱导的突触可塑性和AD病理学中的作用.
主要方法:
- 在AD的APP/PS1小鼠模型中进行了12周的有氧运动干预.
- 认知功能的评估,粉样β (Aβ) 和脑粉样血管病变 (CAA) 的清除.
- 对树突脊柱密度和突触相关蛋白的表达的分析 (CREB,SYN,PSD95).
- 全基因组RNA测序 (RNA-Seq) 和生物信息学分析以确定关键的miRNA.
- 验证miR-3473e表达及其下游目标 (EphB2,Slc1a1,NMDA/AMPA受体) 的有效性.
主要成果:
- 有氧运动显著改善了早期AD小鼠的学习和记忆.
- 运动促进了Aβ和CAA的清除,并增强了树突脊柱的密度.
- 发现miR-3473e在AD大脑中过度表达,并且通过有氧运动下调.
- 有氧运动增加了miR-3473e的下游目标,包括EphB2和NMDA/AMPA受体信号传递的组件.
- 通过抑制miR-3473e和调节EphB2-NMDA/AMPA受体通路,突触可塑性得到增强.
结论:
- 有氧运动通过增强突触可塑性来改善早期AD的认知缺陷.
- 有氧运动的益处是通过抑制miR-3473e.
- 运动调节了EphB2-NMDA/AMPA受体信号通路,有助于突触改善.
- 向miR-3473e代表了与运动相结合的AD治疗的潜在治疗途径.
相关概念视频
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Neuroplasticity
773
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
773
Long-term Potentiation
2.9K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.9K


